Granules USA, Inc. FDA Record
- No warning letters matched by name
Granules USA, Inc. has 1 FDA recall, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Granules USA, Inc." is on file.
- Latest recall
- D-0777-2021 · Class II · Aug 11, 2021
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 1 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 0 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Granules USA, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Granules USA, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0777-2021 | Class II | Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A… | Aug 11, 2021 |
Granules USA, Inc. and the FDA: common questions
Has Granules USA, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Granules USA, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Granules USA, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Granules USA, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
Has Granules USA, Inc. had an FDA recall?
Yes. Granules USA, Inc. has 1 FDA recall on record. The most recent started Aug 11, 2021.
Need more than this page shows? Ask about Granules USA, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.